000 01450 a2200433 4500
005 20250514010018.0
264 0 _c20011204
008 200112s 0 0 eng d
022 _a0300-8630
024 7 _a10.1055/s-2001-16848
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLauten, M
245 0 0 _aClinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter.
_h[electronic resource]
260 _bKlinische Padiatrie
_c
300 _a169-74 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAntineoplastic Agents, Hormonal
650 0 4 _aBlast Crisis
_xblood
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aMale
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aPrednisone
650 0 4 _aPrognosis
650 0 4 _aRisk Factors
650 0 4 _aTreatment Outcome
700 1 _aStanulla, M
700 1 _aZimmermann, M
700 1 _aWelte, K
700 1 _aRiehm, H
700 1 _aSchrappe, M
773 0 _tKlinische Padiatrie
_gvol. 213
_gno. 4
_gp. 169-74
856 4 0 _uhttps://doi.org/10.1055/s-2001-16848
_zAvailable from publisher's website
999 _c11452613
_d11452613